✦ LIBER ✦

Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort

✍ Scribed by Lori L. Davis; John A. Rush; Stephen R. Wisniewski; Kayla Rice; Paolo Cassano; Michele E. Jewell; Melanie M. Biggs; Kathy Shores-Wilson; G.K. Balasubramani; Mustafa M. Husain; Frederic M. Quitkin; Patrick J. McGrath

Book ID: 116379039
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 138 KB
Volume: 46
Category: Article
ISSN: 1532-8384
DOI: 10.1016/j.comppsych.2004.07.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Substance Use Disorder Comorbidity in Ma

Substance Use Disorder Comorbidity in Major Depressive Disorder: A Confirmatory Analysis of the STAR*D Cohort

✍ Lori L. Davis; Elizabeth Frazier; Mustafa M. Husain; Diane Warden; Madhukar Triv 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 88 KB

Does comorbid substance use disorder imp

Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes

✍ Lori L. Davis; Stephen R. Wisniewski; Robert H. Howland; Madhukar H. Trivedi; Mu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 271 KB

EFFECT OF CONCURRENT SUBSTANCE USE DISOR

EFFECT OF CONCURRENT SUBSTANCE USE DISORDER ON THE EFFECTIVENESS OF SINGLE AND COMBINATION ANTIDEPRESSANT MEDICATIONS FOR THE TREATMENT OF MAJOR DEPRESSION: AN EXPLORATORY ANALYSIS OF A SINGLE-BLIND RANDOMIZED TRIAL

✍ Lori L. Davis; Patricia Pilkinton; Stephen R. Wisniewski; Madhukar H. Trivedi; B 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB

Cost Effectiveness Analysis for the Use

Cost Effectiveness Analysis for the Use of Extended Release Quetiapine as Adjunctive Therapy in Mexican Adult Patients with Major Depressive Disorder Non-Responders to Antidepressant Treatment

✍ Polanco, A.C.; Ascencio, I.S.I.; Salazar, A.; González, L.A.; Pizarro, M.; Soto, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB